NCT03994328View on ClinicalTrials.gov

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

CompletedOBSERVATIONAL
Enrollment

1,235

Participants

Timeline

Start Date

December 3, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Parkinson's Disease
Trial Locations (3)

Unknown

Praxis Dr. med. Kirsten Hahn, Berlin

Università degli Studi G. D'Annunzio, Chieti

Corporacio Sanitaria Parc Tauli, Sabadell

All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Zambon SpA

INDUSTRY

NCT03994328 - An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD | Biotech Hunter | Biotech Hunter